A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
מצבים רפואיים
Non-segmental Vitiligo
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Cahaba Derm and skin hlth ctr 27, Birmingham, Alabama, United States
Contact: Principal Investigator (Vlada Groysman)First OC Dermatology, Fountain Valley, California, United States
Contact: Principal Investigator (Vivian Laquer)MedDerm Associates, San Diego, California, United States
Contact: Principal Investigator (Michelle Pelle)Clinical Trials Research Institute, Thousand Oaks, California, United States
Contact: Principal Investigator (Navid Ezra)Encore Medical Research, Hollywood, Florida, United States
Contact: Principal Investigator (Jerome Obed)Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Contact: Principal Investigator (Ashley Wentworth)Miami Derm and Laser Institute, Miami, Florida, United States
Contact: Principal Investigator (Jill Waibel)Global Clinical Professionals, St. Petersburg, Florida, United States
Contact: Principal Investigator (Wanda M Boote)Dawes Fretzin Clinical Rea Group, Indianapolis, Indiana, United States
Contact: Principal Investigator (Kenneth Dawes)Hamzavi Dermatology, Fort Gratiot, Michigan, United States
Contact: Principal Investigator (Iltefat Hamzavi)Revival Research Institute, Troy, Michigan, United States
Contact: Principal Investigator (Ali Moiin)Skin Specialists PC, Omaha, Nebraska, United States
Contact: Principal Investigator (Joel Schlessinger)Las Vegas Dermatology, Las Vegas, Nevada, United States
Contact: Principal Investigator (Harry Lawrence Greenberg)Equity Medical, The Bronx, New York, United States
Contact: Principal Investigator (Michael Cameron)Oregon Medical Research Center, Portland, Oregon, United States
Contact: Principal Investigator (Benjamin D Ehst)International Clinical Research Tennessee LCC, Murfreesboro, Tennessee, United States
Contact: Principal Investigator (Christina Feser)Bellaire Dermatology Associates, Bellaire, Texas, United States
Contact: Principal Investigator (Craig F Teller)Center for Clinical Studies, Houston, Texas, United States
Contact: Principal Investigator (Stephen K Tyring)Austin Inst for Clinical Research, Pflugerville, Texas, United States
Contact: Principal Investigator (Edward Lain)ACRC Trials, Plano, Texas, United States
Contact: Principal Investigator (Seemal Rohit Desai)Virginia Clinical Research, Norfolk, Virginia, United States
Contact: Principal Investigator (David M Pariser)Novartis Investigative Site, Sydney, New South Wales, Australia
Novartis Investigative Site, Waitara, New South Wales, Australia
Novartis Investigative Site, Melbourne, Victoria, Australia
Novartis Investigative Site, Calgary, Alberta, Canada
Novartis Investigative Site, Winnipeg, Manitoba, Canada
Novartis Investigative Site, Mississauga, Ontario, Canada
Novartis Investigative Site, Newmarket, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Québec, Quebec, Canada
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Brest, France
Novartis Investigative Site, Rouen, France
Novartis Investigative Site, Toulouse, France
Novartis Investigative Site, Munich, Bavaria, Germany
Novartis Investigative Site, Bad Bentheim, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Münster, Germany
Novartis Investigative Site, Ahmedabad, Gujarat, India
Novartis Investigative Site, Bangalore, Karnataka, India
Novartis Investigative Site, Belagavi, Karnataka, India
Novartis Investigative Site, Mysore, Karnataka, India
Novartis Investigative Site, Nashik, Maharashtra, India
Novartis Investigative Site, Ancona, AN, Italy
Novartis Investigative Site, Rozzano, MI, Italy
Novartis Investigative Site, Urayasu, Chiba, Japan
Novartis Investigative Site, Kofu, Yamanashi, Japan
Novartis Investigative Site, Niigata, Japan
Novartis Investigative Site, Amsterdam, North Holland, Netherlands
Novartis Investigative Site, Rotterdam, South Holland, Netherlands
Novartis Investigative Site, Barcelona, Spain